Alison has been representing clients before the EPO for over 15 years, both in writing and at oral hearings in Examination, Opposition and Appeal situations. She is known for her excellent strategic patent advice at an international level and liaises with counsel in all major jurisdictions. She has developed a patent practice based on her highly valued technical background and commercial awareness.
Alison’s areas of speciality in biotechnology include signal transduction pathways, cell cycle control, genetic manipulation, bioinformatics, the interleukin pathways, cell therapy, immunology and monoclonal antibody technology. Alison has also established a significant practice in biosimilars, particularly in immunoncology. She also deals with patents in the food and beverage sectors. Alison has a wealth of experience in prosecution and opposition matters and significant success in obtaining, defending and attacking patents before the EPO.
She assists clients in maximising the value of their IP by advising on and obtaining follow-on patents and SPCs. Recognised as a world leading patent attorney in Who’s Who Legal: Patents 2018, she brings a history of success as clients have praised her ''ability to get to the heart of an issue.”
Alison is Kilburn & Strode’s representative at IPO (Intellectual Property Owners) Association and is a regular attendee at their events.
European Patent Attorney
Chartered UK Patent Attorney
IP Litigator - Patent
PhD Genetics (University of Sheffield)
BSc Molecular Biology (University of Leicester)
Chartered Institute of Patent Attorneys (CIPA)
The Institute of Professional Representatives before the European Patent Office (EPI)
Intellectual Property Office (IPO)
'The CIPA Patents Training Manual', Contributing author
A. Care, L. Stallard-Stephens, C. Weston, Patents versus prizes: A Nobel case study, Kilburn & Strode, (2019)